MeSH D008577 - meningeal neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Cytarabine | Cytarabine |  | 1982-01-01 |  |  |
| Cytarabine | Cytosar-u |  | 1998-12-30 |  |  | |
| Mylan | Cytarabine | Cytarabine |  | 2011-12-13 |  |  |
| Rising Pharmaceuticals | Cytarabine | Cytarabine |  | 2011-12-13 |  |  |
| Hospira | Cytarabine | Cytarabine |  | 1990-06-04 |  |  |
| Hikma Pharmaceuticals | Cytarabine | Cytarabine |  | 1989-08-02 |  |  |
| Jazz Pharmaceuticals | Cytarabine, Daunorubicin | Vyxeos (previously Vyxeos) |  | 2018-08-23 |  |  |
| Cytarabine, Daunorubicin | Vyxeos | 2025-04-22 | 2017-08-03 | $146.291 M | Q3/24-Q3/25 | |
| West-Ward Pharmaceutical | Cytarabine | Cytarabine |  | 1994-08-31 |  |  |
| Fresenius Kabi | Cytarabine | Cytarabine |  | 2004-01-15 |  |  |
| Pacira BioSciences | Cytarabine | DepoCyte |  | 2001-07-11 | $1.353 M | Q2/18-Q1/19 |
| Cytarabine | Depocyt |  | 1999-04-01 |  |  | |
| Gland Pharma | Cytarabine | Cytarabine |  | 2019-12-23 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/1
Phase 2
0%0/0
Phase 3
100%3/3
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use